Posts filed under ‘Infecciones en usuarios DIV’

Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of MRSA Infections in Adults and Children: Executive Summary

Clinical Inectious Diseases 1 Feb 2011 V.52 N.3 P.285-292


Catherine Liu1, Arnold Bayer3,5, Sara E. Cosgrove6, Robert S. Daum7, Scott K. Fridkin8, Rachel J. Gorwitz9, Sheldon L. Kaplan10, Adolf W. Karchmer11, Donald P. Levine12, Barbara E. Murray14, Michael J. Rybak12,13, David A. Talan4,5, and Henry F. Chambers1,2

1Department of Medicine, Division of Infectious Diseases, University of California-San Francisco, San Francisco, California

2Division of Infectious Diseases, San Francisco General Hospital, San Francisco, CA

3Division of Infectious Diseases, Harbor-UCLA Medical Center, Torrance, CA

4Divisions of Emergency Medicine and Infectious Diseases, Olive View-UCLA Medical Center, Sylmar, CA

5Department of Medicine, David Geffen School of Medicine at University of California- Los Angeles

6Division of Infectious Diseases, Johns Hopkins Medical Institutions, Baltimore, Maryland

7Department of Pediatrics, Section of Infectious Diseases, University of Chicago, Chicago, Illinois


9Division of Healthcare Quality Promotion, Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia

10Department of Pediatrics, Section of Infectious Diseases, Baylor College of Medicine, Houston, Texas

11Division of Infectious Diseases, Beth Israel Deaconess Medicine Center, Harvard Medical School, Boston, Massachusetts

12 Department of Medicine, Division of Infectious Diseases, Wayne State University, Detroit Receiving Hospital and University Health Center, Detroit, Michigan

13Deparment of Pharmacy Practice, Wayne State University, Detroit Michigan

14Division of Infectious Diseases and Center for the Study of Emerging and Re-emerging Pathogens, University of Texas Medical School, Houston, Texas


Evidence-based guidelines for the management of patients with methicillin-resistant Staphylococcus aureus (MRSA) infections were prepared by an Expert Panel of the Infectious Diseases Society of America (IDSA). The guidelines are intended for use by health care providers who care for adult and pediatric patients with MRSA infections. The guidelines discuss the management of a variety of clinical syndromes associated with MRSA disease, including skin and soft tissue infections (SSTI), bacteremia and endocarditis, pneumonia, bone and joint infections, and central nervous system (CNS) infections. Recommendations are provided regarding vancomycin dosing and monitoring, management of infections due to MRSA strains with reduced susceptibility to vancomycin, and vancomycin treatment failures.



April 2, 2011 at 2:56 pm Leave a comment

Bacterial Infections in Drug Users

Source: N Engl J Med Nov. 3, 2005 Vol 353 N.18 p.1945-1954

Rachel J. Gordon, M.D., M.P.H., and Franklin D. Lowy, M.D.

Illicit drug use is a worldwide health problem. Annually, Approximately 5 percent of the global population, or 200 million people, use illicit drugs.1 In a U.S. survey, 19.5 million people 12 years of age or older, or 8.2 percent of the population, had used an illicit drug in the prior month.2 Injection is one of the most harmful routes of administration. There are an estimated 13 million injection-drug users worldwide, 78 percent of whom live in developing nations.3

Infections are among the most serious complications of drug use.4,5 Drug use plays a major role . . .

[FREE ACCESS Full Text of this Article]

December 22, 2005 at 1:47 am Leave a comment


August 2020

Posts by Month

Posts by Category